EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 139 filers reported holding EPIZYME INC in Q1 2021. The put-call ratio across all filers is 15.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $422,679 | -10.1% | 48,528 | +12.1% | 0.00% | 0.0% |
| Q4 2020 | $470,140 | -43.7% | 43,291 | -16.7% | 0.00% | -60.0% |
| Q2 2020 | $835,000 | -74.5% | 51,982 | -75.4% | 0.01% | -73.0% |
| Q1 2020 | $3,280,000 | -35.1% | 211,400 | +2.9% | 0.04% | -5.1% |
| Q4 2019 | $5,055,000 | +1489.6% | 205,500 | +565.5% | 0.04% | +1850.0% |
| Q3 2019 | $318,000 | -37.0% | 30,877 | -23.2% | 0.00% | -50.0% |
| Q2 2019 | $505,000 | +297.6% | 40,200 | +94.7% | 0.00% | +300.0% |
| Q4 2018 | $127,000 | – | 20,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |